肝硬化患者的维生素D状况和骨健康情况
Indu Grover1, Namrata Singh1, Deepak Gunjan1
1Department of Gastroenterology & Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.
维生素D缺乏和低骨矿物质密度在印度肝硬化患者中非常普遍. 早期查这些疾病对于有效预防和管理这一群体至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 代谢性骨疾病 代谢性骨疾病
背景情况:
- 肝脏是维生素D代谢的核心.
- 肝硬化严重影响维生素D水平和骨健康.
研究的目的:
- 确定印度肝硬化患者中维生素D缺乏 (VDD) 和低骨矿物密度 (BMD) 的患病率.
- 评估肝硬化严重程度与这些疾病之间的关系.
主要方法:
- 对血清25-基维生素D [25(OH) D]水平的前性评估.
- 使用双能X射线吸收计评估骨矿物质密度 (BMD).
- 根据既定指南对VDD,骨质疏松症和骨质疏松症的分类.
主要成果:
- 在350名肝硬化患者中观察到高患病率的VDD (89.4%) 和低的BMD (86%).
- 在不补偿性肝硬化中,VDD和骨质疏松症的患病率更高.
- 体重指数>25公斤/平方米显示对骨健康有保护作用.
结论:
- 维生素D缺乏和低骨矿物质密度在印度肝硬化患者中很普遍.
- 在肝硬化管理中,对VDD和低BMD进行查至关重要.
- 对预防策略的进一步研究是有必要的.
更多相关视频
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
相关概念视频
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Kidney Disease II: Clinical Manifestations
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
